11/25
06:53 am
pgen
Precigen Is Still A Buy After The Papzimeos Rally [Seeking Alpha]
Low
Report
Precigen Is Still A Buy After The Papzimeos Rally [Seeking Alpha]
11/14
02:07 pm
pgen
Vaxart, Precigen among biotech gainers after Q3 results [Seeking Alpha]
Low
Report
Vaxart, Precigen among biotech gainers after Q3 results [Seeking Alpha]
11/14
08:09 am
pgen
Precigen (NASDAQ:PGEN) had its price target raised by analysts at HC Wainwright from $8.50 to $9.00. They now have a "buy" rating on the stock.
High
Report
Precigen (NASDAQ:PGEN) had its price target raised by analysts at HC Wainwright from $8.50 to $9.00. They now have a "buy" rating on the stock.
11/14
12:10 am
pgen
Precigen Inc (PGEN) Q3 2025 Earnings Call Highlights: FDA Approval and U.S. ... [Yahoo! Finance]
High
Report
Precigen Inc (PGEN) Q3 2025 Earnings Call Highlights: FDA Approval and U.S. ... [Yahoo! Finance]
11/6
05:06 pm
pgen
Precigen to Announce Third Quarter 2025 Financial Results and Provide Business Updates on November 13 [Yahoo! Finance]
Low
Report
Precigen to Announce Third Quarter 2025 Financial Results and Provide Business Updates on November 13 [Yahoo! Finance]
11/6
04:30 pm
pgen
Precigen to Announce Third Quarter 2025 Financial Results and Provide Business Updates on November 13
Low
Report
Precigen to Announce Third Quarter 2025 Financial Results and Provide Business Updates on November 13
10/16
05:39 pm
pgen
Patient Opportunity Equity Strategy Q3 2025 Portfolio Recap [Seeking Alpha]
High
Report
Patient Opportunity Equity Strategy Q3 2025 Portfolio Recap [Seeking Alpha]
10/13
07:34 am
pgen
Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis [Yahoo! Finance]
Low
Report
Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis [Yahoo! Finance]
10/13
07:00 am
pgen
Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis
Low
Report
Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis
9/25
10:33 am
pgen
Rapid Medical™ Appoints Industry Veteran Nir Nimrodi to Its Board of Directors [Yahoo! Finance]
Low
Report
Rapid Medical™ Appoints Industry Veteran Nir Nimrodi to Its Board of Directors [Yahoo! Finance]
9/23
07:37 pm
pgen
Precigen, Inc. (PGEN) Secures $125M to Accelerate PAPZIMEOS Commercialization [Yahoo! Finance]
Medium
Report
Precigen, Inc. (PGEN) Secures $125M to Accelerate PAPZIMEOS Commercialization [Yahoo! Finance]
9/23
06:21 pm
pgen
The Outlook For Precigen [Seeking Alpha]
Medium
Report
The Outlook For Precigen [Seeking Alpha]
9/20
03:03 am
pgen
Precigen, Inc. (PGEN) Bolsters Financial Standing to Enhance PAPZIMEOS Commercialization [Yahoo! Finance]
Low
Report
Precigen, Inc. (PGEN) Bolsters Financial Standing to Enhance PAPZIMEOS Commercialization [Yahoo! Finance]
9/12
08:05 pm
pgen
4 years from clinic to approval — Precigen's ‘unprecedented' FDA nod and what comes next [Yahoo! Finance]
Medium
Report
4 years from clinic to approval — Precigen's ‘unprecedented' FDA nod and what comes next [Yahoo! Finance]
9/11
08:15 am
pgen
EVERSANA Named by Precigen for U.S. Commercialization of PAPZIMEOS [Yahoo! Finance]
Low
Report
EVERSANA Named by Precigen for U.S. Commercialization of PAPZIMEOS [Yahoo! Finance]
9/11
03:55 am
pgen
Precigen's (PGEN) Papzimeos Push Sparks Multibagger Ascent, Boosted by Analyst Optimism [Yahoo! Finance]
Medium
Report
Precigen's (PGEN) Papzimeos Push Sparks Multibagger Ascent, Boosted by Analyst Optimism [Yahoo! Finance]